NANORAY-312: A Phase III Pivotal Study of NBTXR3 Activated by Investigator’s Choice of Radiotherapy Alone or Radiotherapy in Combination with Cetuximab for Platinum-Based Chemotherapy- Ineligible Elderly Patients with Locally Advanced HNSCC

For inquiries about our technology, collaborations, clinical trials, or other topics, we encourage you to get in touch with our team.